Who owns Halozyme Therapeutics (HALO)? Superinvestor holders
5 superinvestors of the 157 tracked here hold Halozyme Therapeutics (HALO) in their latest 13F filing, with $656.1M between them. Josef Lakonishok gives it the most weight: 0.31% of the reported portfolio. In their latest reported quarter, George Soros opened a position; Josef Lakonishok and John Overdeck and David Siegel (founders) added; Ray Dalio (founder) and Joel Greenblatt reduced.
Ken Fisher and Richard Pzena sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 5 of 157
- Biggest holder
- John Overdeck and David Siegel (founders), $388.5M
- Largest weight
- Josef Lakonishok, 0.31%of their portfolio
- Combined value
- $656.1M
- Bought last quarter
- 3
- Sold last quarter
- 4
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Josef LakonishokLSV Asset Management | 0.31% | $166.4M | 1.51M | ▲ Added 6.9% | +96.88K | Q3 2026 |
| 2 | John Overdeck and David Siegel (founders)Two Sigma Investments | 0.28% | $388.5M | 3.52M | ▲ Added 113% | +1.87M | Q3 2026 |
| 3 | Ray Dalio (founder)Bridgewater Associates | 0.15% | $36.3M | 463.15K | ▼ Reduced 9.4% | −48.28K | Q2 2026 |
| 4 | Joel GreenblattGotham Asset Management | 0.14% | $57.9M | 739.27K | ▼ Reduced 1.0% | −7.54K | Q2 2026 |
| 5 | George SorosSoros Fund Management | 0.11% | $7.1M | 64.12K | New | +64.12K | Q3 2026 |
Sold out last quarter
- Ken Fisherwas $33.5M · Q3 2026
- Richard Pzenawas $316.9K · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 3 | 5.09M | $562M | 3 | 2 |
| Q2 2026 | 157 | 3 | 1.21M | $94.4M | 0 | 2 |
| Q1 2026 | 157 | 2 | 1.26M | $81.3M | 1 | 2 |
| Q4 2025 | 157 | 1 | 561.58K | $37.8M | 1 | 0 |
| Q3 2025 | 157 | 4 | 4.41M | $323.3M | 4 | 0 |
| Q2 2025 | 157 | 0 | — | — | 0 | 0 |
| Q1 2025 | 156 | 0 | — | — | 0 | 0 |
| Q4 2024 | 156 | 0 | — | — | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| John Overdeck and David Siegel (founders) | 3.52M | — | — | — | — | — | — | — |
| Josef Lakonishok | 1.51M | — | — | — | 1.27M | — | — | — |
| George Soros | 64.12K | — | — | — | — | — | — | — |
| Joel Greenblatt | · | 739.27K | 746.84K | — | — | — | — | — |
| Ray Dalio (founder) | · | 463.15K | 511.43K | 561.58K | 487.08K | — | — | — |
| Richard Pzena | — | 4.05K | — | — | 4.11K | — | — | — |
| David Shaw (founder) | · | — | — | — | 2.65M | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own HALO?
In their latest 13F filings: Josef Lakonishok (0.31% of the portfolio, $166.4M), John Overdeck and David Siegel (founders) (0.28% of the portfolio, $388.5M), Ray Dalio (founder) (0.15% of the portfolio, $36.3M), Joel Greenblatt (0.14% of the portfolio, $57.9M), George Soros (0.11% of the portfolio, $7.1M).
Who bought HALO last quarter?
Josef Lakonishok (added 6.9%), John Overdeck and David Siegel (founders) (added 113%), George Soros (new position). “Last quarter” is each investor's latest reported quarter.
Who sold HALO last quarter?
Reduced: Ray Dalio (founder) (9.4% fewer shares), Joel Greenblatt (1.0% fewer shares). Sold out entirely: Ken Fisher (was $33.5M), Richard Pzena (was $316.9K).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Halozyme Therapeutics (HALO)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/HALO/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to HALO by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.